Connecticut: Regulators Expand Qualifying Conditions Eligible For Cannabis Therapy

Hartford, CT: Patients with severe rheumatoid arthritis, spasticity disorders, and neuropathic facial pain are among those who are now eligible for marijuana therapy following a decision this week by regulators to expand the program’s list of qualifying conditions.

Under the just-announced rules, doctors may for the first time recommend medical cannabis to patients with the following diagnoses: spasticity, severe rheumatoid arthritis, post herpetic neuralgia, hydrocephalus, intractable headache, neuropathic facial pain, muscular dystrophy, and osteogenesis imperfecta (aka broken bone disease).
Over 27,000 Connecticut are currently enrolled in the state’s medical cannabis program.

For more information, contact Paul Armentano, NORML Deputy Director, at: